Norepinephrine versus Dopamine for Septic Shock in Neonates: A Randomized Controlled Trial
Mohammad Yusuf Ali Mazhari1, Mayank Priyadarshi1, Poonam Singh1
1Department of Neonatology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
The Journal of Pediatrics
|April 19, 2025
Summary
Norepinephrine (NE) and dopamine (DA) showed similar effectiveness for treating septic shock in newborns. While both drugs reversed shock similarly, dopamine was linked to more tachycardia and lower cerebral oxygen saturation.
Area of Science:
- Neonatalogy
- Pediatric Critical Care
- Pharmacology
Background:
- Septic shock in neonates is a critical condition requiring prompt vasoactive support.
- Norepinephrine and dopamine are commonly used first-line agents, but their comparative efficacy in neonates is debated.
- Fluid-refractory septic shock necessitates aggressive management to improve outcomes.
Purpose of the Study:
- To compare the efficacy of norepinephrine versus dopamine as the initial vasoactive agent in neonates with fluid-refractory septic shock.
- To evaluate secondary outcomes including time to shock reversal, need for additional medications, and various physiological parameters.
- To assess the safety profile of both agents in this vulnerable population.
Main Methods:
- A randomized controlled trial involving 80 neonates with fluid-refractory septic shock.
- Participants were assigned to receive either norepinephrine (n=41) or dopamine (n=39) as the first-line treatment.
- Vasoactive drug doses were initiated and escalated within defined ranges, with shock reversal at 30 minutes as the primary outcome.
Main Results:
- No significant difference was observed in the proportion of neonates achieving shock reversal at 30 minutes between the norepinephrine and dopamine groups (32% vs. 46%, P=.19).
- Time to shock reversal, requirement for additional vasoactive drugs and steroids, lactate levels, and mortality were comparable between groups.
- The dopamine group exhibited a higher incidence of tachycardia, reduced cerebral tissue oxygen saturation, and lower pH at 24 hours compared to the norepinephrine group.
Conclusions:
- Norepinephrine and dopamine demonstrate comparable efficacy in reversing septic shock in neonates when used as first-line agents.
- While both agents are effective, dopamine use was associated with adverse effects like tachycardia and decreased cerebral oxygenation.
- Further research may be warranted to optimize the selection and titration of vasoactive agents in neonatal septic shock.
Related Concept Videos
01:30Adrenergic Agonists: Therapeutic Uses
750
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
750
01:18Adrenergic Agonists: Therapeutic Classification
751
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
751
01:30Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K
01:27Adrenergic Neurons: Neurotransmission
3.5K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.5K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K